Nanomedicine in Cancer Clinics: Are We There Yet?
Authors (first, second and last of 5)

Current Pathobiology Reports presents expert review articles on important recent research pertaining to the biological mechanisms underlying disease, including etiology, pathogenesis, and the clinical manifestations of cellular alteration. Offering clear, insightful, balanced contributions, the journal serves those for whom the elucidation of new techniques and technologies related to pathobiology is essential.
Coverage extends to such topics as autophagy, cancer stem cells, induced pluripotential stem cells (iPS cells), inflammation and cancer, matrix pathobiology, miRNA in pathobiology, mitochondrial dysfunction/diseases, and myofibroblast.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
© Springer Science+Business Media, LLC, part of Springer Nature